skinny
- 01 Apr 2015 14:34
- 35 of 37
ONVO could be interesting today :-
Micro cap Organovo (NYSEMKT:ONVO) is up 10% premarket on average volume in response to its announcement that it presented data on in vitro three-dimensional kidney tissue at the Experimental Biology conference in Boston.
The 3D tissue, fabricated using the company's NovoGen bioprinter, consists of multiple tissue-relevant cell types arranged to recapitulate the renal tubular/interstitial interface, specifically polarized renal proximal tubular epithelial cells and a living interstitial layer of renal fibroblasts and endothelial cells.
Analyzing the tissue on a slide under a microscope showed evidence of formation of microvascular structures and stable maintenance of the layered architecture for at least two weeks.
skinny
- 22 Apr 2015 14:21
- 36 of 37
Organovo (NYSEMKT:ONVO) enters into a multi-year collaboration agreement with Merck (NYSE:MRK) to develop multiple custom tissue models. The deal includes access to
ONVO's exVive3D Human Liver Tissue service. Financial terms are not disclosed.
ONVO is up 17% premarket on robust volume.
skinny
- 26 May 2015 12:13
- 37 of 37
Gap closure within sight on ATP.